Full Press Release Details
Electromed, Inc. Announces Share Repurchase
NEW PRAGUE, Minn. (March 10, 2025) -
Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced
that on March 6, 2025, its board of directors authorized the repurchase of up to $5.0 million of Electromed common stock.
The timing and amount of share repurchases pursuant
to the authorization, if any, will be determined by management based on market conditions and other considerations. Repurchases may be
made from time to time on the open market at prevailing market prices, in privately negotiated transactions, in block trades and/or through
other legally permissible means, depending on market conditions and in accordance with applicable rules and regulations. Electromed's
board of directors expects to review the share repurchase authorization periodically and may approve changes to its terms and size.
"I am excited to announce Electromed's next share repurchase
authorization, which reflects our confidence in the strength of our business. Our management team and Board are committed to creating
additional shareholder value. We believe deploying our excess cash reserves to opportunistically buy back stock helps us to return capital
to our shareholders while maintaining both a strong balance sheet and the financial flexibility to invest in future growth opportunities,"
said Jim Cunniff, President, and Chief Executive Officer.
About Electromed, Inc.
Electromed manufactures, markets, and sells products
that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function.
Electromed is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.
Cautionary Statements
Certain statements in this press release, including the prospect
of future repurchases of Electromed's equity securities, potential benefits of the same, and Electromed's financial position,
constitute forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements
can generally be identified by words such as "anticipate," "believe," "estimate," "continue,"
"expect," "intend," "may," "plan" "potential," "should," "will,"
and similar expressions, including the negative of these terms, but they are not the exclusive means of identifying such statements. Forward-looking
statements cannot be guaranteed, and actual results may vary materially due to the uncertainties and risks, known or unknown associated
with such statements. Examples of risks and uncertainties for Electromed include, but are not limited to, the competitive nature of our
market; changes to Medicare, Medicaid, or private insurance reimbursement policies; changes to state and federal health care laws; changes
affecting the medical device industry; our ability to develop new sales channels for our products such as the homecare distributor channel;
our need to maintain regulatory compliance and to gain future regulatory approvals and clearances; new drug or pharmaceutical discoveries;
general economic and business conditions; alternative capital deployment opportunities; our ability to renew our line of credit or obtain
additional credit as necessary; our ability to protect and expand our intellectual property portfolio; the risks associated with expansion
into international markets, as well as other factors we may describe from time to time in Electromed's reports filed with the Securities
and Exchange Commission (including Electromed's most recent Annual Report on Form 10-K, as amended from time to time, and subsequent
Quarterly Reports on Form 10-Q and Current Reports on Form 8-K). Investors should not consider any list of such factors to be an exhaustive
statement of all the risks, uncertainties or potentially inaccurate assumptions investors should take into account when making investment
decisions. Shareholders and other readers should not place undue reliance on "forward-looking statements," as such statements
speak only as of the date of this press release. We undertake no obligation to update them in light of new information or future events.